Related Experiment Videos
Periodontal regeneration with enamel matrix derivative--case reports
1amanor@ibm.net
Journal of the International Academy of Periodontology
|April 2, 2003
Summary
Enamel matrix proteins show promise in regenerating periodontal intrabony defects. Clinical application of enamel matrix derivative (Emdogain) supports its use in periodontal surgery for defect regeneration.
Area of Science:
- Periodontal regeneration
- Biomaterials in dentistry
Background:
- Periodontal intrabony defects are a significant challenge in restorative dentistry.
- Enamel matrix proteins have demonstrated potential for inducing regenerative processes.
Observation:
- This study evaluated the preliminary clinical outcomes of enamel matrix protein (Emdogain) use.
- The observation period ranged from 6 to 12 months post-surgery.
- Emdogain was used as an adjunct to periodontal surgical therapy.
Findings:
- Clinical results indicate that enamel matrix derivatives can promote regeneration in intrabony defects.
- Regenerative capacity was observed irrespective of periodontal disease type.
- Effectiveness was noted across various types of intrabony defects.
Implications:
- Enamel matrix proteins represent a viable therapeutic option for periodontal regeneration.
- These findings support the adjunctive use of Emdogain in treating intrabony defects.
- Further research can explore long-term efficacy and broader applications.